Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Sudarshan Pharma Industries's 3-Year ROIIC % for the quarter that ended in Mar. 2026 was 8.28%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Sudarshan Pharma Industries's 3-Year ROIIC % or its related term are showing as below:
BOM:543828's 3-Year ROIIC % is ranked better than 65.36% of 1530
companies
in the Chemicals industry
Industry Median: 0.025
vs BOM:543828: 8.28
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Sudarshan Pharma Industries 3-Year ROIIC % Related Terms
Sudarshan Pharma Industries 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Sudarshan Pharma Industries's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sudarshan Pharma Industries 3-Year ROIIC % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Sudarshan Pharma Industries's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Sudarshan Pharma Industries's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Sudarshan Pharma Industries (BOM:543828) has a 3-Year ROIIC % of 8.28 as of Mar. 2026. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Sudarshan Pharma Industries and its competitors. This is near median its historical median of 8.28. Over the past decade, Sudarshan Pharma Industries' 3-Year ROIIC % has ranged from 6.70 to 12.57. According to the industry distribution chart, Sudarshan Pharma Industries ranks #530 out of 1530 companies in the Chemicals industry, placing it in the top 34.6%.
Is Sudarshan Pharma Industries' 3-Year ROIIC % too high?
Sudarshan Pharma Industries' current 3-Year ROIIC % of 8.28 is near median its 10-year median of 8.28. Over the past 10 years, this metric has ranged from a low of 6.70 to a high of 12.57. The Chemicals industry median 3-Year ROIIC % is 0.03. Sudarshan Pharma Industries' value of 8.28 is 33020% above this industry median. Based on the distribution chart, Sudarshan Pharma Industries ranks #530 out of 1530 companies in the Chemicals industry, which is above the industry midpoint. Overall, Sudarshan Pharma Industries has a GF Score™ of 71/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sudarshan Pharma Industries' 3-Year ROIIC % compare to DOW?
According to the Chemicals industry distribution chart, Sudarshan Pharma Industries ranks #530 out of 1530 companies for 3-Year ROIIC %. This puts Sudarshan Pharma Industries in the upper half of its industry. The industry median 3-Year ROIIC % is 0.03. Sudarshan Pharma Industries' value of 8.28 is 33020% above this benchmark. Historically, Sudarshan Pharma Industries' own 3-Year ROIIC % has ranged from 6.70 to 12.57 over the past decade. While the company's 10-year median is 8.28 vs. the industry median of 0.03, Sudarshan Pharma Industries has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Chemicals company?
The median 3-Year ROIIC % among Chemicals companies is 0.03, based on 1,530 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sudarshan Pharma Industries's current 3-Year ROIIC % of 8.28 is 33020% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Sudarshan Pharma Industries and its competitors. For the Chemicals industry, the median 3-Year ROIIC % is 0.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sudarshan Pharma Industries's current 3-Year ROIIC % is 8.28, which is near median its own 10-year median of 8.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sudarshan Pharma Industries stock overvalued right now?
Based on GuruFocus' analysis, Sudarshan Pharma Industries (BOM:543828) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹24.96, compared to a current price of ₹39.87 — trading 59.7% above its estimated fair value. The current 3-Year ROIIC % is 8.28, which is near median its 10-year median of 8.28 and 33020% above the Chemicals industry median of 0.03. Sudarshan Pharma Industries' overall GF Score™ is 71/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Sudarshan Pharma Industries (BOM:543828), the current 3-Year ROIIC % is 8.28 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sudarshan Pharma Industries (BOM:543828) Overvalued in 2026?
Based on GuruFocus' analysis, Sudarshan Pharma Industries stock appears to be overvalued.
The current stock price of ₹39.87 is trading 59.7% above its estimated GF Value™ of ₹24.96.
GuruFocus considers Sudarshan Pharma Industries to be Significantly Overvalued.
Key valuation signals for BOM:543828:
3-Year ROIIC %: 8.28 (near median its 10-year median of 8.28)
GF Value™: ₹24.96 vs. price of ₹39.87 (59.7% above fair value)
Industry Position: 33020% above the Chemicals median (#530 of 1530)
No single metric tells the full story. See the BOM:543828 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sudarshan Pharma Industries Ltd operates in the pharmaceutical and chemical industries, focusing on specialty chemicals and intermediates used in pharmaceuticals, paints, food products, and adhesives. The Company has a presence domestically and internationally, participating regularly in trade fairs and exhibitions. The Company exports mainly to South East Asia, the Middle East, and North Africa. The Company also supplies generic pharmaceutical formulation as 'Make to order' for bulk supply to hospitals and related healthcare organisations. The company has one reportable segment of Specialty Chemicals.
71GF Score
Get the complete analysis for BOM:543828
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543828 has been successfully added to your 
